Product Information
FLECAINIDE ACETATE 150 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2690 per EA under NDC 65862062301. Its NADAC has been published 570 times since Nov 4, 2015.
FDA first approved this application on Nov 3, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862062301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLECAINIDE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA202821FDA Approved
11/3/2017
TE Code
AB
On Market Since
11/3/2017
Pharmacological Classes
Price Statistics
The NADAC for FLECAINIDE ACETATE 150 MG TAB has been published 570 times since Nov 4, 2015, and over the history we have for it it has declined 61.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2690 per EA |
|---|---|
| All-time high | $0.8144 (Apr 13, 2016) |
| All-time low | $0.1778 (Nov 20, 2024) |
| 52-week high | $0.3088 |
| 52-week low | $0.2537 |
| Median price | $0.4801 |
| Average price | $0.4717 |
| Largest weekly change | -41.4% (Nov 20, 2024) |
| Weeks tracked | 570 |
| Tracking since | Nov 4, 2015 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Flecainide Acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiarrhythmic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLECAINIDE ACETATE 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for FLECAINIDE ACETATE 150 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.2690 per EA (NDC 65862062301), effective Sep 30, 2026.
How has the price of FLECAINIDE ACETATE 150 MG TAB changed over time?
Over the history we have for it, the NADAC for FLECAINIDE ACETATE 150 MG TAB has declined 61.7%. It has been tracked across 570 weekly CMS publications since Nov 4, 2015.
What are the highest and lowest recorded NADAC prices for FLECAINIDE ACETATE 150 MG TAB?
Since Nov 4, 2015, the NADAC for FLECAINIDE ACETATE 150 MG TAB has ranged from a low of $0.1778 (Nov 20, 2024) to a high of $0.8144 (Apr 13, 2016), with a median of $0.4801 per EA.
Are there cheaper alternatives to FLECAINIDE ACETATE 150 MG TAB?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLECAINIDE ACETATE 150 MG TAB, is $0.2559 per EA — about 5% below FLECAINIDE ACETATE 150 MG TAB.
Who manufactures FLECAINIDE ACETATE 150 MG TAB?
FLECAINIDE ACETATE 150 MG TAB (NDC 65862062301) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.